Vishnu Amaram Samara Simha Subhash Chandra
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 7 | 2023 | 117 | 2.460 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2021 | 241 | 0.940 |
Why?
|
| Macrophage Activation | 2 | 2020 | 49 | 0.860 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2021 | 140 | 0.850 |
Why?
|
| Chondrogenesis | 1 | 2021 | 28 | 0.790 |
Why?
|
| Angiotensin II | 1 | 2021 | 93 | 0.770 |
Why?
|
| Inflammation | 4 | 2023 | 971 | 0.670 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 219 | 0.650 |
Why?
|
| Obesity | 1 | 2020 | 966 | 0.430 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 258 | 0.410 |
Why?
|
| Monocytes | 2 | 2023 | 218 | 0.400 |
Why?
|
| Up-Regulation | 3 | 2021 | 727 | 0.340 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 37 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1176 | 0.300 |
Why?
|
| Arteries | 1 | 2018 | 180 | 0.280 |
Why?
|
| Cytokines | 2 | 2020 | 802 | 0.250 |
Why?
|
| Down-Regulation | 2 | 2021 | 519 | 0.240 |
Why?
|
| Macrophages | 3 | 2023 | 571 | 0.230 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2021 | 4 | 0.200 |
Why?
|
| Kidney Function Tests | 1 | 2022 | 113 | 0.200 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2021 | 21 | 0.200 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 26 | 0.200 |
Why?
|
| Tropomyosin | 1 | 2021 | 16 | 0.200 |
Why?
|
| Aggrecans | 1 | 2021 | 43 | 0.200 |
Why?
|
| src-Family Kinases | 1 | 2021 | 76 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 1237 | 0.190 |
Why?
|
| Creatinine | 1 | 2022 | 293 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 275 | 0.190 |
Why?
|
| Muscle Contraction | 1 | 2021 | 284 | 0.180 |
Why?
|
| Poly ADP Ribosylation | 1 | 2020 | 2 | 0.180 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2020 | 25 | 0.180 |
Why?
|
| Aorta | 1 | 2021 | 288 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2023 | 255 | 0.170 |
Why?
|
| Osteogenesis | 1 | 2021 | 255 | 0.170 |
Why?
|
| Animals | 7 | 2023 | 27317 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 280 | 0.170 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 121 | 0.160 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 223 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 199 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 3209 | 0.150 |
Why?
|
| Male | 6 | 2022 | 42251 | 0.150 |
Why?
|
| Rats | 2 | 2021 | 4040 | 0.150 |
Why?
|
| Phenotype | 2 | 2021 | 2439 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 607 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2021 | 899 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2020 | 259 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 191 | 0.150 |
Why?
|
| Chromatin | 1 | 2020 | 397 | 0.140 |
Why?
|
| Kidney | 1 | 2022 | 1145 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2018 | 599 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2018 | 458 | 0.130 |
Why?
|
| Cell Line | 1 | 2020 | 2495 | 0.130 |
Why?
|
| Humans | 8 | 2023 | 89063 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 559 | 0.110 |
Why?
|
| Hypertension | 1 | 2018 | 741 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1650 | 0.100 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 506 | 0.100 |
Why?
|
| THP-1 Cells | 1 | 2021 | 5 | 0.100 |
Why?
|
| Mice | 4 | 2023 | 11737 | 0.090 |
Why?
|
| Female | 3 | 2022 | 46011 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2018 | 459 | 0.060 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2023 | 3 | 0.060 |
Why?
|
| Palmitic Acid | 1 | 2023 | 27 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2018 | 3373 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2023 | 465 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1975 | 0.040 |
Why?
|
| NADPH Oxidase 1 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Young Adult | 1 | 2021 | 6288 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2018 | 7 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 16 | 0.040 |
Why?
|
| Streptozocin | 1 | 2018 | 55 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2018 | 86 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 153 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2018 | 261 | 0.040 |
Why?
|
| Protein Binding | 1 | 2018 | 1487 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1855 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2880 | 0.030 |
Why?
|
| Adult | 1 | 2021 | 26507 | 0.020 |
Why?
|